Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

An Uniquely Designed Asymmetric Bispecific Antibody Against GPRC5D and CD3 (LBL-034) in Patients with Relapsed/Refractory Multiple Myeloma: A Phase I/II, First in Human, Open-Label, Multicenter, Dose Escalation/Expansion Study

Ling Qin, Yuping Zhong, Dongping Huang, Haitang Xie, Xin Du, Aijun Liao, Hongli Zhang, Shengli (Charles) Cai, Jin Lu

Blood (2024) 144 (Supplement 1): 4736.

https://doi.org/10.1182/blood-2024-202871

Published: 2024

Journal Articles

A Phase 1 Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor (BCL-2i), in Patients (pts) with Certain Relapsed or Refractory (R/R) Hematologic Malignancies (HMs)

Mingyuan Sun, Junyuan Qi, Zi Chen, Hongli Zhang, Yongping Song, Aizong Shen, Huilan Liu, Jianying Huang, Fuling Zhou, Jie Jin, Ming Lu, Mohammad Ahmad, Lichuang Men, Wan Cen, Dajun Yang, Jianxiang Wang, Yifan Zhai

Blood (2021) 138 (Supplement 1): 3730.

https://doi.org/10.1182/blood-2021-152235

Published: 2021

Journal Articles

Colony-Forming Unit Cell (CFU-C) Assays in Myelodysplastic Syndrome

Bing Li, MD, Jinqin Liu, Shiqiang Qu, MD, Robert Peter Gale, MD PhD DSc, Ruixian Xing, Tiejun Qin, Yue Zhang, MD, Zefeng Xu, MD, Liwei Fang, Hongli Zhang, MD, Lijuan Pan, Naibo Hu, Gang Huang, PhD, Zhijian Xiao, MD

Blood (2015) 126 (23): 2874.

https://doi.org/10.1182/blood.V126.23.2874.2874

Published: 2015

Journal Articles

Impact of Megakaryocyte Morphology on Prognosis of Persons with Myelodysplastic Syndromes

Gege Feng, MD, Wen Cui, Wenyu Cai, Tiejun Qin, Yue Zhang, MD, Zefeng Xu, MD, Liwei Fang, Hongli Zhang, MD, Lijuan Pan, Naibo Hu, Bing Li, MD, Zhijian Xiao, MD

Blood (2015) 126 (23): 2876.

https://doi.org/10.1182/blood.V126.23.2876.2876

Published: 2015

Journal Articles

Prognostic Impact of Splenomegaly on Survival of Chinese with Primary Myelofibrosis

Jingya Wang, Junqing Xu, Robert Peter Gale, MD PhD DSc, FACP, Zefeng Xu, MD, Bing Li, Tiejun Qin, Yue Zhang, Liwei Fang, Hongli Zhang, Lijuan Pan, Shiqiang Qu, Peihong Zhang, Zhijian Xiao, MD

Blood (2014) 124 (21): 3210.

https://doi.org/10.1182/blood.V124.21.3210.3210

Published: 2014

NARROW

An Uniquely Designed Asymmetric Bispecific Antibody Against GPRC5D and CD3 (LBL-034) in Patients with Relapsed/Refractory Multiple Myeloma: A Phase I/II, First in Human, Open-Label, Multicenter, Dose Escalation/Expansion Study

A Phase 1 Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor (BCL-2i), in Patients (pts) with Certain Relapsed or Refractory (R/R) Hematologic Malignancies (HMs)

Colony-Forming Unit Cell (CFU-C) Assays in Myelodysplastic Syndrome

Impact of Megakaryocyte Morphology on Prognosis of Persons with Myelodysplastic Syndromes

Prognostic Impact of Splenomegaly on Survival of Chinese with Primary Myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

An Uniquely Designed Asymmetric Bispecific Antibody Against GPRC5D and CD3 (LBL-034) in Patients with Relapsed/Refractory Multiple Myeloma: A Phase I/II, First in Human, Open-Label, Multicenter, Dose Escalation/Expansion Study

A Phase 1 Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor (BCL-2i), in Patients (pts) with Certain Relapsed or Refractory (R/R) Hematologic Malignancies (HMs)

Colony-Forming Unit Cell (CFU-C) Assays in Myelodysplastic Syndrome

Impact of Megakaryocyte Morphology on Prognosis of Persons with Myelodysplastic Syndromes

Prognostic Impact of Splenomegaly on Survival of Chinese with Primary Myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only